Department of Pain Medicine, BG University Hospital Bergmannsheil GmbH, Ruhr University, Bochum, Germany.
Department Internal and Integrative Medicine, Faculty of Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Germany.
Eur J Pain. 2019 Jan;23(1):3-14. doi: 10.1002/ejp.1284. Epub 2018 Aug 6.
This systematic review aimed at evaluating the efficacy, acceptability and safety of Internet-based psychological therapies (IPTs) in fibromyalgia syndrome (FMS). Clinicaltrials.gov, Cochrane Library, MEDLINE, PsycINFO and SCOPUS were searched from inception to January 2018. Randomized controlled trials (RCTs) comparing IPTs with controls were analysed. Primary outcomes were ≥50% pain relief, disability, negative mood, acceptability and safety at end of therapy and at 6-month follow up. Effects were summarized by a random effects model using risk differences (RD) or standardized mean differences (SMD) with 95% confidence intervals (CI). Six RCTs using different types of Internet-based cognitive-behavioural therapies [ICBTs] (acceptance-based; exposure-based; traditional) with 493 patients were included. At the end of treatment, ICBTs were superior to controls (waiting list, attention control, treatment as usual) in reducing negative mood (SMD -0.51 [95% CI -0.87 to -0.15]) (moderate quality evidence) and disability (SMD -0.56 [95% CI -1.00 to -0.13]) (moderate quality evidence). There were no statistically significant differences between ICBTs and controls in pain relief of 50% or greater (RD 0.09 [95% CI -0.02 to 0.20] (moderate quality evidence) and acceptability (moderate quality evidence). No data on safety and any outcomes at long-term follow-up compared to controls were found. The data available did not allow statistical comparisons between unguided and guided ICBTs and of ICBTs versus traditional face-to-face therapies. ICBTs provided a clinically relevant benefit over control interventions in reducing negative mood and disability at the end of treatment. SIGNIFICANCE: Internet-delivered cognitive behavioural therapies provided a clinically relevant benefit in reducing negative mood and disability in patients with FMS at the end of treatment if compared to waiting list, treatment as usual and attention controls.
本系统评价旨在评估基于互联网的心理疗法(IPT)在纤维肌痛综合征(FMS)中的疗效、可接受性和安全性。检索了临床对照试验数据库(Clinicaltrials.gov)、考科蓝图书馆(Cochrane Library)、医学文献在线数据库(MEDLINE)、心理文献数据库(PsycINFO)和 Scopus,检索时间截至 2018 年 1 月。分析了比较 IPT 与对照组的随机对照试验(RCT)。主要结局为治疗结束时和 6 个月随访时疼痛缓解≥50%、残疾、负性情绪、可接受性和安全性。采用随机效应模型,使用风险差异(RD)或标准化均数差(SMD)及其 95%置信区间(CI)来总结效应。纳入了 6 项使用不同类型基于互联网的认知行为疗法(ICBT)[接受性为基础;暴露性为基础;传统性]的 RCT,共纳入 493 名患者。治疗结束时,ICBT 与对照组(等待名单、注意对照、常规治疗)相比,在减轻负性情绪(SMD-0.51[95%CI-0.87 至-0.15])(中等质量证据)和残疾(SMD-0.56[95%CI-1.00 至-0.13])(中等质量证据)方面更优。在疼痛缓解 50%或以上(RD0.09[95%CI-0.02 至 0.20])(中等质量证据)和可接受性(中等质量证据)方面,ICBT 与对照组之间无统计学差异。未发现与对照组相比的安全性和任何长期随访结果的数据。现有的数据不允许对无指导和有指导的 ICBT 之间以及 ICBT 与传统面对面治疗之间进行统计学比较。与对照组相比,ICBT 在治疗结束时提供了一种临床相关的治疗获益,可以减轻负性情绪和残疾。意义:与等待名单、常规治疗和注意对照相比,基于互联网的认知行为疗法在纤维肌痛综合征患者的治疗结束时可提供一种临床相关的治疗获益,可以减轻负性情绪和残疾。